Assessing the Prognostic Implications of Myocardial Perfusion Studies: Identification of Patients at Risk vs Patients who May Benefit from Intervention?
- First Online:
Stress myocardial perfusion imaging (MPI) has a well-established role in improving risk stratification. Recent analyses, compared with older data, suggest that the yield of stress MPI has decreased. In part, this trend relates to testing patients with heterogeneous, but improved, risk factor modification. In this setting, positron emission tomography with myocardial flow reserve enhances risk stratification as it reflects the end result of atherosclerosis. Recent studies have also emphasized the clinical impact of incremental risk stratification by assessing net reclassification improvement (NRI). Previous retrospective studies have favored an ischemic threshold to select patients that benefit from revascularization, but this finding has not been corroborated in randomized trials. However, no large randomized trial has directly tested a strategy of revascularization for patients with at least a moderate amount of ischemia at risk. Unfortunately, even when faced with a significantly abnormal MPI result, subsequent action is too often absent.
KeywordsCoronary artery disease Diabetes mellitus Early revascularization Myocardial perfusion imaging Single photon emission computed tomography Positron emission tomography Net reclassification improvement Myocardial flow reserve
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation. 1998;97:535–43.PubMedCrossRefGoogle Scholar
- 3.Hachamovitch R, Hayes SW, Friedman JD, et al. Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD. J Am Coll Cardiol. 2004;43:200–8.PubMedCrossRefGoogle Scholar
- 4.••Rozanski A, Gransar H, Hayes SW, et al. Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing1991 to 2009. J Am Coll Cardiol. 2013;61:1054–65. This study documents the decline in abnormal SPECT tests over the past 2 decades even though pre-test probability of CAD did not decrease. Google Scholar
- 5.•Shaw LJ, Wilson PWF, Hachamovitch R, et al. Improved near-term coronary artery disease risk classification with gated stress myocardial perfusion SPECT. J Am Coll Cardiol Imaging. 2010;3:1139–48. This study demonstrated NRI with SPECT ischemia. Google Scholar
- 6.•Dorbala S, Di Carli MF, Beanlands RS, et al. Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry. J Am Coll Cardiol. 2013;61:176–84. This study demonstrated NRI with PET ischemia and/or scar. Google Scholar
- 7.Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, et al. ACC/AHA/ACP–ASIM Guidelines for the Management of Patients With Chronic Stable Angina: Executive Summary and Recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). Circulation. 1999;99:2829–48.PubMedCrossRefGoogle Scholar
- 9.•Murthy VL, Naya M, Foster CR, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011;124:2215–24. There is a significant NRI with PET MFR even when added to clinical and other imaging variables. Google Scholar
- 11.Zellweger MJ, Lewin HC, Lai S, et al. When to stress patients after coronary artery bypass surgery? Risk stratification in patients early and late post-CABG using stress myocardial perfusion SPECT: implications of appropriate clinical strategies. J Am Coll Cardiol. 2001;37:144–52.PubMedCrossRefGoogle Scholar
- 13.••Aldweib N, Negishi K, Hachamovitch R, et al. Impact of repeat myocardial revascularization on outcome in patients with silent ischemia after previous revascularization. J Am Coll Cardiol. 2013;61:1616–23. This study showed that imaging variables did not prognosticate asymptomatic patients after revascularization and outcomes were not improved with repeat revascularization. Google Scholar
- 18.••Murthy VL, Naya M, Foster CR, et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012;126:1858–68. This study showed that diabetics without known CAD but with reduced MFR were at similar risk as diabetics with CAD. Google Scholar
- 19.The BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360:2503–15.Google Scholar
- 20.•Shaw LJ, Cerqueira MD, Brooks MM, et al. Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. J Nucl Cardiol. 2012;19:658–69. Upon follow-up SPECT of diabetics with CAD, fixed perfusion defect was the strongest predictor of cardiac event, and patients assigned to revascularization had less perfusion abnormality. Google Scholar
- 21.Hachamovitch R, Hayes SW, Friedman JD, et al. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107:2900–7.PubMedCrossRefGoogle Scholar
- 22.•Hachamovitch R, Rozanski A, Shaw LJ, et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J. 2011;32:1012–24. In patients without significant scar and moderate to severe ischemia on SPECT MPI, survival was improved with early revascularization. Google Scholar
- 24.Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) Trial nuclear substudy. Circulation. 2008;117:1283–91.PubMedCrossRefGoogle Scholar
- 26.•Shaw LJ, Weintraub WS, Maron DJ, et al. Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. Am Heart J. 2012;164:243–50. Most SPECT tests inCOURAGE were not interpreted in a core lab and a six 6-segment model was used, raising issues about reliability and generalizability. Google Scholar
- 28.••ISCHEMIA. Available at https://www.ischemiatrial.org/. A randomized controlled trial that is enrolling to assess whether patients with moderate to severe ischemia benefit from early revascularization.
- 35.Hachamovitch R, Fong Ling L, Jaber WA, Brunken RC, Cerqueira MC, Marwick TH. Impact of LV remodeling on the threshold of jeopardized myocardium needed for a survival benefit with CABG in patients with left ventricular systolic dysfunction: was STICH too simplistic? Circulation. 2012;126:A16450.Google Scholar
- 36.••Hachamovitch R, Nutter B, Hlatky MA, et al. Patient management after noninvasive cardiac imaging: results from SPARC (Study of Myocardial Perfusion and Coronary Anatomy Imaging Roles in Coronary Artery Disease). J Am Coll Cardiol. 2012;59:462–74. Rates of changes in medical therapy and referral to cardiac catheterization were low after moderately to severely abnormal stress tests. Google Scholar